Literature DB >> 20146584

WWOX gene and gene product: tumor suppression through specific protein interactions.

Zaidoun Salah1, Rami Aqeilan, Kay Huebner.   

Abstract

The WWOX gene, an archetypal fragile gene, encompasses a chromosomal fragile site at 16q23.2, and encodes the approximately 46-kDa Wwox protein, with WW domains that interact with a growing list of interesting proteins. If the function of a protein is defined by the company it keeps, then Wwox is involved in numerous important signal pathways for bone and germ-cell development, cellular and animal growth and death, transcriptional control and suppression of cancer development. Because alterations to genes at fragile sites are exquisitely sensitive to replication stress-induced DNA damage, there has been an ongoing scientific discussion questioning whether such gene expression alterations provide a selective advantage for clonal expansion of neoplastic cells, and a parallel discussion on why important genes would be present at sites that are susceptible to inactivation. We offer some answers through a description of known WWOX functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146584      PMCID: PMC2832309          DOI: 10.2217/fon.09.152

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  90 in total

1.  Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23.

Authors:  Ethan M Lange; Jennifer L Beebe-Dimmer; Anna M Ray; Kimberly A Zuhlke; Jaclyn Ellis; Yunfei Wang; Sarah Walters; Kathleen A Cooney
Journal:  Prostate       Date:  2009-03-01       Impact factor: 4.104

Review 2.  WWOX, the tumour suppressor gene affected in multiple cancers.

Authors:  U Lewandowska; M Zelazowski; K Seta; M Byczewska; E Pluciennik; A K Bednarek
Journal:  J Physiol Pharmacol       Date:  2009-05       Impact factor: 3.011

Review 3.  WWOX: its genomics, partners, and functions.

Authors:  Sara Del Mare; Zaidoun Salah; Rami I Aqeilan
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

Review 4.  Fhit tumor suppressor: guardian of the preneoplastic genome.

Authors:  Flavia Pichiorri; Tiziana Palumbo; Sung-Suk Suh; Hiroshi Okamura; Francesco Trapasso; Hideshi Ishii; Kay Huebner; Carlo M Croce
Journal:  Future Oncol       Date:  2008-12       Impact factor: 3.404

5.  WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.

Authors:  Charlie Gourley; Adam J W Paige; Karen J Taylor; Carol Ward; Barbara Kuske; Jieqing Zhang; Mingjun Sun; Szymon Janczar; David J Harrison; Morwenna Muir; John F Smyth; Hani Gabra
Journal:  Cancer Res       Date:  2009-05-19       Impact factor: 12.701

6.  Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.

Authors:  Gulnur Guler; Kay Huebner; Cigdem Himmetoglu; Rafael E Jimenez; Stefan Costinean; Stefano Volinia; Robert T Pilarski; Mutlu Hayran; Charles L Shapiro
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

Review 7.  Fragile gene product, Fhit, in oxidative and replicative stress responses.

Authors:  Hiroshi Okumura; Hideshi Ishii; Flavia Pichiorri; Carlo M Croce; Masaki Mori; Kay Huebner
Journal:  Cancer Sci       Date:  2009-03-23       Impact factor: 6.716

8.  The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities.

Authors:  Valeria Naim; Filippo Rosselli
Journal:  Nat Cell Biol       Date:  2009-05-24       Impact factor: 28.824

9.  Replication stress induces sister-chromatid bridging at fragile site loci in mitosis.

Authors:  Kok Lung Chan; Timea Palmai-Pallag; Songmin Ying; Ian D Hickson
Journal:  Nat Cell Biol       Date:  2009-05-24       Impact factor: 28.824

10.  Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein.

Authors:  N Bouteille; K Driouch; P El Hage; S Sin; E Formstecher; J Camonis; R Lidereau; F Lallemand
Journal:  Oncogene       Date:  2009-05-25       Impact factor: 9.867

View more
  53 in total

1.  Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.

Authors:  Kyle C Kurek; Sara Del Mare; Zaidoun Salah; Suhaib Abdeen; Hussain Sadiq; Suk-Hee Lee; Eugenio Gaudio; Nicola Zanesi; Kevin B Jones; Barry DeYoung; Gail Amir; Mark Gebhardt; Matthew Warman; Gary S Stein; Janet L Stein; Jane B Lian; Rami I Aqeilan
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation.

Authors:  Zaidoun Salah; Sherri Cohen; Ella Itzhaki; Rami I Aqeilan
Journal:  Cell Cycle       Date:  2013-10-07       Impact factor: 4.534

3.  WW domain containing oxidoreductase induces apoptosis in gallbladder-derived malignant cell by upregulating expression of P73 and PUMA.

Authors:  Dong Wei; Xiaowen Zhang; Hao Zou; Lin Wang; Bimang Fu; Xuesong Wu; Zhiling Luo; Xiao Li; Jiayun Ge; Yuehua Li; Hong Zhu; Kun Wang; Tao Wang; Pei Yang; Zongliu Hou; Wenju Wang
Journal:  Tumour Biol       Date:  2013-10-15

4.  Downregulation of WW domain-containing oxidoreductase leads to tamoxifen-resistance by the inactivation of Hippo signaling.

Authors:  Juan Li; Xuefei Feng; Canyu Li; Jie Liu; Pingping Li; Ruiqi Wang; He Chen; Peijun Liu
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-02

5.  Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma.

Authors:  Sara Del Mare; Kyle C Kurek; Gary S Stein; Jane B Lian; Rami I Aqeilan
Journal:  Am J Cancer Res       Date:  2011-04-03       Impact factor: 6.166

Review 6.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 7.  Alteration of WWOX in human cancer: a clinical view.

Authors:  Izabela Baryła; Ewa Styczeń-Binkowska; Andrzej K Bednarek
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-13

8.  Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.

Authors:  Mohammad Abu-Odeh; Tomer Bar-Mag; Haiming Huang; TaeHyung Kim; Zaidoun Salah; Suhaib K Abdeen; Marius Sudol; Dana Reichmann; Sachdev Sidhu; Philip M Kim; Rami I Aqeilan
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

9.  Conditional inactivation of the mouse Wwox tumor suppressor gene recapitulates the null phenotype.

Authors:  Suhaib K Abdeen; Sara Del Mare; Sadeeq Hussain; Muhannad Abu-Remaileh; Zaidoun Salah; John Hagan; Maysoon Rawahneh; Xin-An Pu; Stacey Russell; Janet L Stein; Gary S Stein; Jane B Lian; Rami I Aqeilan
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

Review 10.  WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.

Authors:  C Marcelo Aldaz; Brent W Ferguson; Martin C Abba
Journal:  Biochim Biophys Acta       Date:  2014-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.